GlassScriptPhysician profile
Anthony Albert Romeo
NPI 1013996891
$26,845,427.38
in general payments reported to CMS, 2019-2025
18 companies · $5.4M in 2025
The $5.4M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2.4M · 2020: $2.5M · 2021: $3.1M · 2022: $4.3M · 2023: $4.4M · 2024: $4.8M · 2025: $5.4M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $14M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $249K · Consulting Fee: $108K · Travel and Lodging: $12K · Food and Beverage: $3,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $14,251,706.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $249,327.76 |
| Consulting Fee | $108,416.75 |
| Travel and Lodging | $12,434.03 |
| Food and Beverage | $3,415.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $26,455,934.70 | 2019-2025 | Arthrex, Ar-9301-02 |
| Depuy Synthes Sales INC. | $387,544.07 | 2021-2022 | |
| Medwest Associates | $477.19 | 2021-2023 | |
| Alpha Orthopedic Systems | $212.58 | 2022 | |
| Exactech, INC. | $191.39 | 2020 | |
| Left Coast Surgical INC | $173.14 | 2025 | |
| Pacira Therapeutics, INC. | $159.91 | 2019 | |
| Acumed LLC | $149.47 | 2019 | |
| Gotham Surgical Solutions & Devices, INC. | $144.44 | 2022 | |
| Legacy Ortho LLC | $114.83 | 2025 | |
| Stryker Corporation | $98.36 | 2022 | |
| Heron Therapeutics, INC. | $95.74 | 2022-2023 | Zynrelef |
| Djo, LLC | $48.62 | 2019 | |
| Medtronic USA, INC. | $30.69 | 2020 | |
| Zimmer Biomet Holdings, INC. | $30.03 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $22.22 | 2023 | Maci |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$375,005.34 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Romeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.